对三种药监系统评估工具的比较分析
Muhammad Akhtar Abbas Khan1,2, Jude Nwokike3, Asim Rauf2
1Department of Public Health, Health Services Academy, Islamabad, Pakistan.
评估国家药监系统需要仔细选择工具. 评估基于指标的药监测评估工具 (IPAT),世卫组织药监测指标和世卫组织全球基准分析工具 (GBT) 揭示了它们的独特优势和局限性,以便进行全面分析.
科学领域:
- 药物监督 药物监督 药物监督
- 药物安全评估 药物安全评估
- 监管科学 监管科学
背景情况:
- 国家药监系统对于监测药物安全至关重要.
- 关键的评估工具包括基于指标的药监测评估工具 (IPAT),世界卫生组织 (WHO) 药监测指标和世卫组织全球基准测试工具 (GBT).
- 这些工具评估了国家监管机构在药监监管中的功能.
研究的目的:
- 识别,分析和比较主要药监督评估工具的核心特征.
- 了解IPAT,世卫组织药监指标和GBT的范围,应用和限制.
- 为评估国家药监系统提供最佳实践信息.
主要方法:
- 对三种已识别的药监测评估工具进行结构化文档分析.
- 工具内容的系统审查,分类和综合.
- 对工具设计,重点领域和评估标准的比较评估.
主要成果:
- 现有的工具涵盖了各种各样的药物监督维度:基础设施,流程和结果.
- 完全依赖单一的工具为国家药监监管框架提供了一个有限的视角.
- 评估工具之间存在异质性,影响了它们的全面应用.
结论:
- 药物监督评估工具的具体环境调整至关重要.
- 多种工具的战略选择或整合确保了全面的评估.
- 为准确评估国家药监系统,建议采用量身定制的方法.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
